Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4HXV0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 6 |
GO:0005488 | binding | 1 | 8 |
GO:0008270 | zinc ion binding | 6 | 6 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0046914 | transition metal ion binding | 5 | 6 |
GO:0097159 | organic cyclic compound binding | 2 | 6 |
GO:1901363 | heterocyclic compound binding | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.578 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.439 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.580 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.448 |
CLV_PCSK_PC1ET2_1 | 44 | 46 | PF00082 | 0.582 |
DOC_MAPK_gen_1 | 73 | 81 | PF00069 | 0.439 |
DOC_MAPK_RevD_3 | 61 | 75 | PF00069 | 0.501 |
DOC_PP4_FxxP_1 | 19 | 22 | PF00568 | 0.570 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.755 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.605 |
LIG_14-3-3_CanoR_1 | 16 | 20 | PF00244 | 0.505 |
LIG_Actin_WH2_2 | 75 | 90 | PF00022 | 0.519 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.651 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.443 |
LIG_LIR_Apic_2 | 18 | 22 | PF02991 | 0.377 |
LIG_LIR_Gen_1 | 66 | 77 | PF02991 | 0.568 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.618 |
LIG_PDZ_Class_1 | 91 | 96 | PF00595 | 0.480 |
LIG_PTB_Apo_2 | 22 | 29 | PF02174 | 0.439 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.480 |
LIG_TRAF2_1 | 90 | 93 | PF00917 | 0.541 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.569 |
MOD_CK2_1 | 87 | 93 | PF00069 | 0.477 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.729 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.458 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.751 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.649 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.565 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.653 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.560 |
MOD_PKA_1 | 44 | 50 | PF00069 | 0.460 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.501 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.496 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.580 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.566 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.603 |
MOD_SUMO_rev_2 | 85 | 90 | PF00179 | 0.644 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.523 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.445 |
TRG_NLS_MonoExtC_3 | 43 | 49 | PF00514 | 0.613 |
TRG_NLS_MonoExtN_4 | 41 | 48 | PF00514 | 0.623 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P725 | Trypanosomatidae | 49% | 91% |
A0A3Q8I9Z0 | Leishmania donovani | 99% | 100% |
A4H9I7 | Leishmania braziliensis | 85% | 100% |
E9ARL3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QDW6 | Leishmania major | 90% | 100% |
V5BM68 | Trypanosoma cruzi | 57% | 100% |